Status:

COMPLETED

Urinary miRNA in Endometrial Cancer Study

Lead Sponsor:

Royal Cornwall Hospitals Trust

Conditions:

Endometrial Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

This study is a prospective feasibility study with the addition of a retrospective cohort study on the the expression of microRNA in urine in endometrial cancer patients.

Eligibility Criteria

Inclusion

  • Confirmed diagnosis of endometrial cancer
  • Age: 18 years or older

Exclusion

  • Prior or coexisting other malignancies
  • Autoimmune disorders (other than diabetes mellitus)

Key Trial Info

Start Date :

March 8 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 26 2020

Estimated Enrollment :

164 Patients enrolled

Trial Details

Trial ID

NCT03824613

Start Date

March 8 2019

End Date

March 26 2020

Last Update

March 1 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal Cornwall Hospital

Truro, Cornwal, United Kingdom, TR13LJ